Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep1041 | Thyroid (non-cancer) | ECE2015

Surgical treatment of thyroid disease: descriptive analysis and histopathology of a series of 92 cases

Ma Calderon Dulce , Aranda Jaime , Mondejar Jose , Alramadan Mubarak , Martin David , Perez Jose

Introduction: Retrospective study of patients undergoing thyroid surgery at the Hospital Virgen de la Luz, Cuenca (Spain) during the years 2010–2013.Material and methods: We evaluated data of 92 patients basically with nodular thyroid disease, who were studied and treated in our hospital.Results: Our series is made up of 92 patients (25% men and 75% women) with an average age of 52 years. The most common form of presentation (...

ea0056p1188 | Thyroid cancer | ECE2018

Descriptive study about clinical and surgical characteristics of patients with differentiated thyroid cancer in our health area

Gonzalez Javier , Calderon Dulce Maria , Marton David , Al-Ramadan Mubarak , Perez Jose

Introduction, material and methods: Differentiated thyroid cancer is a pretty common reason for consulting in our specialty. In general terms, the prognosis is good in the main histological type but there are many others that can worsen the prognosis. It can determine the kind of surgery from hemithyroidectomy (e.g. microcarcinoma) to no intervention because of its extension at the moment of diagnosis. We have collected the data of our patients with differentiated thyroid canc...

ea0032p319 | Clinical case reports - Thyroid / Others | ECE2013

Everolimus. a new therapeutic target in the metastatic neuroendocrine carcinoma

Rodriguez Jose Perez , Hernandez Tomas Martin , Hernandez Cristina , Baz David Vicente , Manzano Virginia Martin , Baldrich Alfonso Gentil , Perez Angel Sendon

Introduction: Everolimus is a drug selective inhibitor of mTOR and approved by the FDA in 2011 for treatment of neuroendocrine tumors of pancreatic origin unresectable. Our objective was to evaluate the efficacy and safety of everolimus in a patient with malignant pancreatic head insulinoma.Case: This is a 31 year old man who complains of epigastric pain, dizziness, sweating and syncope related to exercise. During admission is objectively severe hypoglyc...

ea0032p479 | Diabetes | ECE2013

Insulinator: a computer program to help in the insulin therapy

Rodriguez Jose Perez , Portillo Cristobal Morales , Jimenez Virginia Hernando , Cobos Manuel Malagon , Olmedo Isabel Serrano , Perez Angel Sendon

Introduction and objectives: In clinical practice many professionals are involved in the diabetes treatment. To facilitate this work, we present a computer program, based in recommended guidelines, to improve the management of insulin therapy, called insulinator. We evaluated the correlation between these and clinical practice.Materials and methods: Insulinator has been made so that using a number of variables (weight, HbA1c and glycemic control) offer a...

ea0032p1112 | Thyroid cancer | ECE2013

Ultrasound guided enolization as a therapeutic alternative in local recurrences of papillary thyroid carcinoma

Hernandez Tomas Martin , Rodriguez Jose Perez , Rivera Natividad Gonzalez , Cuadro Alberto Torres , Garcia Clara Garcia , Manzano Virginia Martin

Introduction and objectives: Multiple surgeries are associated with many complications in the local recurrence of papillary thyroid carcinoma. Our objective is to evaluate the efficiency of the enolization in the recurrent metastatic cervical lymph nodes in patients with limited nodal disease.Material and methods: We studied 13 patients (six males and seven females) with a mean age of 43±14.4 years with papillary thyroid carcinoma intervened (total ...

ea0056p1203 | Thyroid cancer | ECE2018

Comparative study about differences in staging and prognosis in patients affected or not of BRAF V600E mutation

Gonzalez Javier , Calderon Dulce Maria , Alramadan Mubarak , Perez Jose , Martin David , Acedo Raquel , Jimenez Fulgencio , Campos Yolanda

Introduction, material and methods: The BRAF isoform of RAF has been implicated in the pathogenesis of papillary thyroid cancer, but not of benign or follicular neoplasms. Also, BRAF mutations may confer a worse clinical prognosis than for papillary thyroid cancer without the BRAF mutation. Recurrence occurs more frequently when BRAF mutations are present. In addition, BRAF mutations are associated with extrathyroidal invasion, lymph node me...

ea0063gp19 | Calcium and Bone 1 | ECE2019

18F-Fluorocholine PET/CT in patients with primary Hyperparathyroidism and negative or inconclusive 99mTc-MIBI parathyroid scan: clinico-pathological correlations

Minambres Inka , Farran Judit Amigo , Lopez Diego Alfonso , Estorch Montserrat , Perez Jose Ignacio , Moral Antonio , Clos Montserrat , Ballester Eulalia , Chico Ana

Introduction: The gold standard for evaluating Occult Parathyroid Adenomas (OPa) in patients with biochemical pattern of primary hyperparathyroidism (PHPT) is the 99mTc-MIBI parathyroid scan. 18F-Fluorocholine (18F-FCH) PET/CT has been proposed as a potential technique for detection and localization of OPa when 99mTc-MIBI scan is negative or inconclusive.Aims: To evaluate sensitivity and positive predictive value of 18F-Fluorocholine PET/CT in patients w...

ea0041ep597 | Endocrine tumours and neoplasia | ECE2016

Phaeochromocytomas and paragangliomas: A comparative study between sporadic and familial cases in a reference care center in Spain

Luis Guillermo Ropero , Perez Jose Angel Diaz , Gracia Teresa Ruiz , Hernandez Martin Cuesta , Hoyos Emilia Gomez , Hernandez Irene Crespo , Novoa Paz de Miguel

Introduction: Hereditary phaeochromocytoma (PCC) and paraganglioma (PGL) account for 30–35% of cases and have some clinically relevant peculiarities.Material and methods: Retrospective, unicentric cohort study that included all genotyped patients (n=36, 27 with PCC and 9 with PGL) diagnosed at Hospital Clínico San Carlos (Madrid) between 1984 and 2013; 33% were germline mutation carriers (25% pseudohypoxic [PH] phenotype, 75% MAP-kinas...

ea0041ep603 | Endocrine tumours and neoplasia | ECE2016

Medullary Thyroid Cancer: a comparative study between sporadic and familial cases in a reference care center in Spain

Luis Guillermo Ropero , Perez Jose Angel Diaz , Hoyos Emilia Gomez , Hernandez Martin Cuesta , Hernandez Irene Crespo , Gracia Teresa Ruiz , de Miguel Novoa Paz

Introduction: Hereditary Medullary Thyroid Cancer (MTC) accounts for 20–30% of cases and has some clinically relevant peculiarities.Material and methods: Retrospective, unicentric cohort study that included all genotyped patients with MTC (n=48) diagnosed at Hospital Clínico San Carlos (Madrid) between 1984–2013; 42% were germline mutation carriers (45% moderate risk (category MOD), 45% high risk (category H), 10% highest risk (ca...

ea0035p51 | Adrenal cortex | ECE2014

The adrenal venous sampling is a difficult test in the localization of the primary hyperaldosteronism

Rodriguez Jose Perez , Jimenez Virginia Hernando , Hernandez Tomas Martin , Cuadro Alberto Torres , Rivera Natividad Gonzalez , Baldrich Alfonso Gentil , Cobos Manuel Malagon

Introduction and objectives: The localization of primary hyperaldosteronism is often difficult. The coexistence of nonfunctioning adenomas is common in patients older 40 years old and small adenomas undetectable by CT could confuse with bilateral hyperplasia. The AVS is considered the ‘gold standard’ test for the location of numerous guides. We describe our experience in a clinical case of primary aldosteronism.Clinical case: We present a 58 ye...